Andlauer Healthcare Group Inc.
Andlauer Healthcare Group Inc. (ANDHF) Financial Performance & Income Statement Overview
Review Andlauer Healthcare Group Inc. (ANDHF) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Andlauer Healthcare Group Inc. (ANDHF) Income Statement & Financial Overview
View the income breakdown for Andlauer Healthcare Group Inc. ANDHF across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $166.09M | $168.29M | $159.60M | $161.45M |
| Cost of Revenue | $129.34M | $128.79M | $122.37M | $125.03M |
| Gross Profit | $36.75M | $39.50M | $37.23M | $36.42M |
| Gross Profit Ratio | $0.22 | $0.23 | $0.23 | $0.23 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $15.18M | $12.76M | $13.42M | $14.24M |
| Operating Expenses | $15.18M | $12.76M | $13.42M | $14.24M |
| Total Costs & Expenses | $144.52M | $141.55M | $135.79M | $139.27M |
| Interest Income | $323000.00 | $260000.00 | $494000.00 | $703000.00 |
| Interest Expense | $1.96M | $2.11M | $2.19M | $1.71M |
| Depreciation & Amortization | $17.94M | $17.62M | $17.37M | $17.60M |
| EBITDA | $45.34M | $43.83M | $41.81M | $39.78M |
| EBITDA Ratio | $0.27 | $0.26 | $0.26 | $0.25 |
| Operating Income | $21.57M | $26.74M | $23.81M | $22.18M |
| Operating Income Ratio | $0.13 | $0.16 | $0.15 | $0.14 |
| Other Income/Expenses (Net) | $3.88M | -$2.64M | -$1.55M | -$702000.00 |
| Income Before Tax | $25.45M | $24.10M | $22.26M | $21.47M |
| Income Before Tax Ratio | $0.15 | $0.14 | $0.14 | $0.13 |
| Income Tax Expense | $5.22M | $6.57M | $5.97M | $5.74M |
| Net Income | $20.23M | $17.53M | $16.29M | $15.73M |
| Net Income Ratio | $0.12 | $0.10 | $0.10 | $0.10 |
| EPS | $0.50 | $0.44 | $0.41 | $0.38 |
| Diluted EPS | $0.49 | $0.43 | $0.41 | $0.38 |
| Weighted Avg Shares Outstanding | $40.28M | $39.25M | $39.39M | $41.11M |
| Weighted Avg Shares Outstanding (Diluted) | $40.88M | $39.84M | $39.95M | $41.76M |
Over the last four quarters, Andlauer Healthcare Group Inc.'s revenue moved from $161.45M in Q2 2024 to $166.09M in Q1 2025. Operating income in Q1 2025 was $21.57M, with a strong operating margin of 13%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Andlauer Healthcare Group Inc. remained robust at $45.34M, reflecting operational efficiency. Net income rose to $20.23M, with an EPS of $0.50. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan